JP2022536739A5 - - Google Patents

Info

Publication number
JP2022536739A5
JP2022536739A5 JP2021573732A JP2021573732A JP2022536739A5 JP 2022536739 A5 JP2022536739 A5 JP 2022536739A5 JP 2021573732 A JP2021573732 A JP 2021573732A JP 2021573732 A JP2021573732 A JP 2021573732A JP 2022536739 A5 JP2022536739 A5 JP 2022536739A5
Authority
JP
Japan
Application number
JP2021573732A
Other languages
Japanese (ja)
Other versions
JP2022536739A (ja
JPWO2020252214A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/037325 external-priority patent/WO2020252214A1/en
Publication of JP2022536739A publication Critical patent/JP2022536739A/ja
Publication of JP2022536739A5 publication Critical patent/JP2022536739A5/ja
Publication of JPWO2020252214A5 publication Critical patent/JPWO2020252214A5/ja
Priority to JP2025207503A priority Critical patent/JP2026032195A/ja
Pending legal-status Critical Current

Links

JP2021573732A 2019-06-12 2020-06-11 関節リウマチのための皮下トシリズマブの改良された投薬量 Pending JP2022536739A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025207503A JP2026032195A (ja) 2019-06-12 2025-11-28 関節リウマチのための皮下トシリズマブの改良された投薬量

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962860611P 2019-06-12 2019-06-12
US62/860,611 2019-06-12
EP20305192.5 2020-02-27
EP20305192 2020-02-27
PCT/US2020/037325 WO2020252214A1 (en) 2019-06-12 2020-06-11 Modified dosage of subcutaneous tocilizumab for rheumatoid arthritis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025207503A Division JP2026032195A (ja) 2019-06-12 2025-11-28 関節リウマチのための皮下トシリズマブの改良された投薬量

Publications (3)

Publication Number Publication Date
JP2022536739A JP2022536739A (ja) 2022-08-18
JP2022536739A5 true JP2022536739A5 (https=) 2023-06-16
JPWO2020252214A5 JPWO2020252214A5 (https=) 2023-06-16

Family

ID=71170831

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021573732A Pending JP2022536739A (ja) 2019-06-12 2020-06-11 関節リウマチのための皮下トシリズマブの改良された投薬量
JP2025207503A Pending JP2026032195A (ja) 2019-06-12 2025-11-28 関節リウマチのための皮下トシリズマブの改良された投薬量

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025207503A Pending JP2026032195A (ja) 2019-06-12 2025-11-28 関節リウマチのための皮下トシリズマブの改良された投薬量

Country Status (13)

Country Link
US (1) US20220242959A1 (https=)
EP (1) EP3983071A1 (https=)
JP (2) JP2022536739A (https=)
KR (1) KR20230047944A (https=)
CN (1) CN115003382A (https=)
AU (1) AU2020290484A1 (https=)
BR (1) BR112021025060A2 (https=)
CA (1) CA3143261A1 (https=)
CO (1) CO2022000064A2 (https=)
IL (1) IL288690A (https=)
MA (1) MA56190A (https=)
MX (1) MX2021015336A (https=)
WO (1) WO2020252214A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020261431A1 (en) 2019-04-24 2021-12-09 Regeneron Pharmaceuticals, Inc. Methods of diagnosis and treatment of rheumatoid arthritis
EP3980459A1 (en) 2019-06-04 2022-04-13 Sanofi Biotechnology Compositions and methods for treating pain in subj ects with rheumatoid arthritis
CN115825415B (zh) * 2022-09-28 2023-07-14 珠海重链生物科技有限公司 阻断剂和体外免疫诊断产品、应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2401040A (en) 2003-04-28 2004-11-03 Chugai Pharmaceutical Co Ltd Method for treating interleukin-6 related diseases
TWI603738B (zh) * 2010-11-08 2017-11-01 建南德克公司 皮下投予抗-il-6受體抗體

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
JP2022519828A5 (https=)
BR112021017747A2 (https=)
JP2022536739A5 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)